14-22982144-C-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_032876.6(AJUBA):āc.123G>Cā(p.Leu41Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000286 in 1,610,210 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_032876.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AJUBA | NM_032876.6 | c.123G>C | p.Leu41Phe | missense_variant | 1/8 | ENST00000262713.7 | NP_116265.1 | |
AJUBA | NM_001289097.2 | c.123G>C | p.Leu41Phe | missense_variant | 1/2 | NP_001276026.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AJUBA | ENST00000262713.7 | c.123G>C | p.Leu41Phe | missense_variant | 1/8 | 1 | NM_032876.6 | ENSP00000262713 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152212Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000367 AC: 9AN: 245258Hom.: 1 AF XY: 0.0000601 AC XY: 8AN XY: 133014
GnomAD4 exome AF: 0.0000281 AC: 41AN: 1457880Hom.: 0 Cov.: 31 AF XY: 0.0000290 AC XY: 21AN XY: 725264
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152330Hom.: 0 Cov.: 33 AF XY: 0.0000403 AC XY: 3AN XY: 74484
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 09, 2021 | The c.123G>C (p.L41F) alteration is located in exon 1 (coding exon 1) of the AJUBA gene. This alteration results from a G to C substitution at nucleotide position 123, causing the leucine (L) at amino acid position 41 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at